1Professor, Department of Economics, VISTAS
2Professor and Head, Department of BBA, VISTAS
Online published on 11 July, 2019.
Number one Sector of producing Hepatitis b Vaccine recombinant in the world is Indian biotechnology Sector. India has the potential to become a major producer of transgenic and various Generic Modified (GM) or Engineered Vegetables for the global food requirement. The modus operandi of this study is exposes the strength, Weakness, Opportunities and Challenges of biotech sector in connection with Foreign Direct Investment. Chapter one provides a basic idea about the Indian biotechnology sector. Chapter two enlists the review of literature. Chapter three envisages the role of FDI on Indian biotechnology sector. Chapter four portrays the current status of Indian Biotechnology sector. Chapter five depicts the SWOT analysis of Economic Impact of FDI on Indian biotechnology sector and last chapter concludes the scope of Indian biotechnology sector and Discussion on future prospects of Indian biotechnology sector.
FDI, Economic Impact, Biotechnology, BIRAC, Generic Modified Technology